Fig. 2From: Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic riskIncidence of delayed CINV by risk factor. The graph displays analyses of incidences of delayed CINV of male (black bars) and female (white bars) between the 2 antiemetics group and the 3 antiemetics groupBack to article page